Although the majority of clinical variables have a positive trend across the patients who received ACEinh/ARB/HMGRi drugs, the associations were not statistically significant.
← all excerpts
Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study.
2
—
—
The sentences
Mortality rate and the number of intubated patients were lower in patients taking ARBs, ACEinhs, and HMGRis, although these differences failed to reach statistical significance.